<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ABD486C6-C73C-47C6-8BA3-9B0B087C9464"><gtr:id>ABD486C6-C73C-47C6-8BA3-9B0B087C9464</gtr:id><gtr:name>Lipoxen Technologies Limited</gtr:name><gtr:address><gtr:line1>5TH FLOOR 15 , WHITEHALL</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SW1A 2DD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ABD486C6-C73C-47C6-8BA3-9B0B087C9464" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>ABD486C6-C73C-47C6-8BA3-9B0B087C9464</gtr:id><gtr:name>Lipoxen Technologies Limited</gtr:name><gtr:address><gtr:line1>5TH FLOOR 15 , WHITEHALL</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SW1A 2DD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>230143.0</gtr:offerGrant><gtr:projectCost>460285.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EB38DD1F-E01A-4709-B86C-F7412F3726D6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>EB38DD1F-E01A-4709-B86C-F7412F3726D6</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Wellington House</gtr:line1><gtr:line2>133-155 Waterloo Road</gtr:line2><gtr:postCode>SE1 8UG</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>23490.0</gtr:offerGrant><gtr:projectCost>47159.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8FD7755-D481-4474-AE08-4DE2B2E0ED61" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>A8FD7755-D481-4474-AE08-4DE2B2E0ED61</gtr:id><gtr:name>M N L Pharma Limited</gtr:name><gtr:address><gtr:line1>PRICEWATERHOUSECOOPERS LLP , BENSON HOUSE</gtr:line1><gtr:city>33 WELLINGTON STREET</gtr:city><gtr:postCode>LS1 4JP</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>88120.0</gtr:offerGrant><gtr:projectCost>176240.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3023E903-DAE0-41CB-91E2-91D648EC40E5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3023E903-DAE0-41CB-91E2-91D648EC40E5</gtr:id><gtr:name>Cambridge Biostability Limited</gtr:name><gtr:address><gtr:line1>SALISBURY HOUSE 3 SALISBURY VILLAS , STATION ROAD</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB1 2LA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>947770.0</gtr:offerGrant><gtr:projectCost>1895549.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>215685.0</gtr:offerGrant><gtr:projectCost>431370.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=150026"><gtr:id>1D24612F-5FB9-4FE7-B16A-605EC2E15150</gtr:id><gtr:title>Controlled Release Nanoparticle vaccines</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>150026</gtr:grantReference><gtr:abstractText>No abstract available.</gtr:abstractText><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1505208</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">150026</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>